UCSF Adult Inpatient Susceptibility Data (Gram-Negatives)1
R-testing not applicable to organism and should be considered resistant, CFPM-cefepime, CIP-ciprofloxacin, CTAZ-ceftazidime, CTRX-ceftriaxone, ERTA-ertapenem, IMI-imipenem-cilastatin, MER-meropenem, P/T-piperacillin-tazobactam, TOB-tobramycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
Organism |
Total Isolates |
CFPM |
CIP |
CTAZ |
CTRX |
ERTA |
IMI/MER2 |
P/T |
TOB |
|---|---|---|---|---|---|---|---|---|---|
|
Weighted average |
2357 |
86 |
74 |
85 |
61 (77)3 |
77 (98)3 |
964 |
86 |
89 |
|
Citrobacter freundii |
57 |
96 |
78 |
N/A |
N/A |
98 |
100 |
N/A |
82 |
|
Enterobacter cloacae |
147 |
87 |
90 |
N/A |
N/A |
87 |
95 |
N/A |
89 |
|
Escherichia coli |
904 |
82 |
64 |
86 |
77 |
99 |
99 |
92 |
86 |
|
Klebsiella aerogenes |
72 |
97 |
95 |
N/A |
N/A |
98 |
91 |
N/A |
97 |
|
Klebsiella oxytoca |
105 |
89 |
85 |
91 |
82 |
97 |
98 |
85 |
87 |
|
Klebsiella pneumoniae |
331 |
79 |
72 |
79 |
74 |
97 |
98 |
82 |
85 |
|
Proteus mirabilis |
172 |
94 |
73 |
99 |
90 |
100 |
100 |
98 |
88 |
|
Pseudomonas aeruginosa |
486 |
90 |
81 |
89 |
N/A |
N/A |
89 |
83 |
97 |
|
Serratia marcescens |
83 |
98 |
89 |
100 |
96 |
98 |
98 |
98 |
97 |
1Adult inpatient susceptibilities include data from 1/1/2024 - 12/31/2024; 2Reflects % susceptibility for imipenem-cilastatin in all situations except for Proteus mirabilis, where % susceptibility for meropenem (non-urine isolates, 85 total isolates) is reported; 3Parentheses excludes Pseudomonas isolates; 4Weighted average excludes 172 Proteus mirabilis isolates tested against imipenem